CN104800443B - A kind of raw marrow symplectic bone agent of kidney tonifying - Google Patents
A kind of raw marrow symplectic bone agent of kidney tonifying Download PDFInfo
- Publication number
- CN104800443B CN104800443B CN201510167338.0A CN201510167338A CN104800443B CN 104800443 B CN104800443 B CN 104800443B CN 201510167338 A CN201510167338 A CN 201510167338A CN 104800443 B CN104800443 B CN 104800443B
- Authority
- CN
- China
- Prior art keywords
- radix
- bone
- kidney tonifying
- fracture
- radix angelicae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000000988 bone and bone Anatomy 0.000 title claims abstract description 21
- 210000003734 kidney Anatomy 0.000 title claims abstract description 21
- 208000010392 Bone Fractures Diseases 0.000 claims abstract description 29
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 12
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 11
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 11
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 11
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 11
- 241001148782 Davallia Species 0.000 claims abstract description 11
- 241000123589 Dipsacus Species 0.000 claims abstract description 11
- 239000009636 Huang Qi Substances 0.000 claims abstract description 11
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 11
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 11
- 235000008422 Schisandra chinensis Nutrition 0.000 claims abstract description 11
- 229910052802 copper Inorganic materials 0.000 claims abstract description 11
- 239000010949 copper Substances 0.000 claims abstract description 11
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 11
- 210000000582 semen Anatomy 0.000 claims abstract description 11
- 241000717739 Boswellia sacra Species 0.000 claims abstract description 10
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 10
- 239000004863 Frankincense Substances 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000000126 substance Substances 0.000 claims abstract description 7
- 230000000694 effects Effects 0.000 abstract description 26
- 239000003814 drug Substances 0.000 abstract description 23
- 201000010099 disease Diseases 0.000 abstract description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 208000002193 Pain Diseases 0.000 abstract description 8
- 230000036407 pain Effects 0.000 abstract description 7
- 208000005214 Poroma Diseases 0.000 abstract description 6
- 201000001013 eccrine acrospiroma Diseases 0.000 abstract description 6
- 210000004185 liver Anatomy 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 4
- 239000003124 biologic agent Substances 0.000 abstract description 2
- 210000002805 bone matrix Anatomy 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 abstract description 2
- 210000000963 osteoblast Anatomy 0.000 abstract description 2
- 230000003014 reinforcing effect Effects 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 230000009466 transformation Effects 0.000 abstract description 2
- 238000011282 treatment Methods 0.000 description 29
- 229940079593 drug Drugs 0.000 description 16
- 206010017076 Fracture Diseases 0.000 description 15
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 208000027418 Wounds and injury Diseases 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 230000000202 analgesic effect Effects 0.000 description 6
- 206010052428 Wound Diseases 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 230000006378 damage Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241000345998 Calamus manan Species 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 238000012913 prioritisation Methods 0.000 description 2
- 235000012950 rattan cane Nutrition 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000024779 Comminuted Fractures Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010017081 Fracture delayed union Diseases 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 208000032912 Local swelling Diseases 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000012642 Sexual Trauma Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000002266 amputation Methods 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000000537 nasal bone Anatomy 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 210000004417 patella Anatomy 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000002303 tibia Anatomy 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of raw marrow symplectic bone agent of the kidney tonifying of accelerating union of bone fracture, it is made of the bulk pharmaceutical chemicals of following parts by weight: native copper 45-55g, rhizome of davallia 12-18g, teasel 10-15g, Semen Cuscutae 10-15g, Schisandra chinensis 10-15g, radix cyathulae 12-18g, Radix Salviae Miltiorrhizae 12-18g, Caulis Spatholobi 12-18g, Eupolyphoge sinensis 12-18g, olibanum 10-15g, myrrh 10-15g, safflower 10-15g, Radix Angelicae Sinensis 10-15g, Radix Astragali 25-35g, Radix Paeoniae Alba 12-18g, rhizoma alismatis 10-15g, Herba Lycopi 10-15g, Radix Angelicae Pubescentis 10-15g, Rhizoma Chuanxiong 10-15g, Radix Glycyrrhizae 8-10g, it is decocted in water for oral dose, the present invention passes through reasonable compatibility, the synergistic effect of each Chinese medicine, treating both manifestation and root cause of disease, it can pass through Adjusting and reinforcing liver and kidney promotes growth of spur, improves the activity and quantity of osteoblast, promotes calcified bone matrix, accelerates poroma transformation, moreover it is possible to alleviate local pain, have more advantages than simple compound and biological agent.
Description
Technical field
The invention belongs to technical field of traditional Chinese medicines, the raw marrow symplectic bone agent of the kidney tonifying of specifically a kind of accelerating union of bone fracture.
Background technique
Whole body sexual trauma caused by wound violence, contingency, traumatic injury is common clinical frequently-occurring disease, severe trauma
Not only threat to life, and rehabilitation course is with the passing of time, many complication and sequelae often occurs, seriously affects quality of life, clinic is controlled
It is intricate to treat, therefore often occurs fracturing in wound middle and later periods recovery process, in the course of disease and not connect, and wound repeated infection is not cured
It closes, soft tissue bruise does not restore, and the absorption of local hematoma difficulty, treatment of traumatic pain and dysfunction etc., differential diagnosis in tcm category liver kidney is not
Foot, stagnation of the circulation of vital energy blood is tired, and muscles and bones is lost, wet poison retention feeding in honor and do not gone.
There are many fresh fracture, old fracture, fracture delayed union and the treatment method of disunion, and corresponding drug is also very
It is more, other than the most basic reduction of the fracture, fixation, the big principle of functional training three, separately there are traction therapeutic, Boards wall, gypsum solid
Still there is sizable delayed union and bone nonunion fractured than regular meeting after fixed, jig braking and various operative treatments fracture,
As dislocation again occurs for the activity of patient or disunion or even deformity cause amputation during treating and healing, trouble is given
The life of person brings inevitable massive losses, while also increasing certain burden for society.
Motherland's medicine thinks that the growth and development of the kidney generating marrow and dominating bone, bone is all related with kidney.Traumatic injury, local swelling are
Stagnation of the circulation of vital energy blood is called, not general rule pain.
Summary of the invention
The purpose of the present invention is to overcome the deficiency of existing above-mentioned technology, and the kidney tonifying for providing a kind of accelerating union of bone fracture is raw
Marrow symplectic bone agent.
To solve the above problems, the technical scheme adopted by the invention is that:
A kind of raw marrow symplectic bone agent of the kidney tonifying of accelerating union of bone fracture, is made: native copper 45- of the bulk pharmaceutical chemicals of following parts by weight
55g, rhizome of davallia 12-18g, teasel 10-15g, Semen Cuscutae 10-15g, Schisandra chinensis 10-15g, radix cyathulae 12-18g, Radix Salviae Miltiorrhizae 12-
18g, Caulis Spatholobi 12-18g, Eupolyphoge sinensis 12-18g, olibanum 10-15g, myrrh 10-15g, safflower 10-15g, Radix Angelicae Sinensis 10-15g, Radix Astragali
25-35g, Radix Paeoniae Alba 12-18g, rhizoma alismatis 10-15g, Herba Lycopi 10-15g, Radix Angelicae Pubescentis 10-15g, Rhizoma Chuanxiong 10-15g, Radix Glycyrrhizae 8-10g, decocting
Clothes.
It is that the present invention advanced optimizes above scheme below:
A kind of raw marrow symplectic bone agent of the kidney tonifying of accelerating union of bone fracture, is made: native copper of the bulk pharmaceutical chemicals of following parts by weight
50g, rhizome of davallia 15g, teasel 12g, Semen Cuscutae 12g, Schisandra chinensis 12g, radix cyathulae 15g, Radix Salviae Miltiorrhizae 15g, Caulis Spatholobi 15g, Eupolyphoge sinensis
15g, olibanum 12g, myrrh 12g, safflower 12g, Radix Angelicae Sinensis 12g, Radix Astragali 30g, Radix Paeoniae Alba 15g, rhizoma alismatis 12g, Herba Lycopi 12g, Radix Angelicae Pubescentis 12g,
Rhizoma Chuanxiong 12g, Radix Glycyrrhizae 9g, is decocted in water for oral dose.
Another prioritization scheme: a kind of raw marrow symplectic bone agent of the kidney tonifying of accelerating union of bone fracture, by the raw material of following parts by weight
Medicine is made: native copper 45g, rhizome of davallia 12g, teasel 10g, Semen Cuscutae 10g, Schisandra chinensis 10g, radix cyathulae 12g, Radix Salviae Miltiorrhizae 12g, chicken
Blood rattan 12g, Eupolyphoge sinensis 12g, olibanum 10g, myrrh 10g, safflower 10g, Radix Angelicae Sinensis 10g, Radix Astragali 25g, Radix Paeoniae Alba 12g, rhizoma alismatis 10g, Herba Lycopi
10g, Radix Angelicae Pubescentis 10g, Rhizoma Chuanxiong 10g, Radix Glycyrrhizae 8g are decocted in water for oral dose.
Another prioritization scheme: a kind of raw marrow symplectic bone agent of the kidney tonifying of accelerating union of bone fracture, by the raw material of following parts by weight
Medicine is made: native copper 55g, rhizome of davallia 18g, teasel 15g, Semen Cuscutae 15g, Schisandra chinensis 15g, radix cyathulae 18g, Radix Salviae Miltiorrhizae 18g, chicken
Blood rattan 18g, Eupolyphoge sinensis 18g, olibanum 15g, myrrh 15g, safflower 15g, Radix Angelicae Sinensis 15g, Radix Astragali 35g, Radix Paeoniae Alba 18g, rhizoma alismatis 15g, Herba Lycopi
15g, Radix Angelicae Pubescentis 15g, Rhizoma Chuanxiong 15g, Radix Glycyrrhizae 10g are decocted in water for oral dose.
In above-mentioned prescription: native copper has effects that removing blood stasis and acesodyne, reunion of fractured tendons and bones；The rhizome of davallia has The strong bone of kidney tonifying, promoting blood circulation
The effect of analgesic；Teasel, which has, cures mainly aching pain in waist and back；Podomere flaccidity syndrome and arthralgia syndrome；Fall the effect of flutterring wound, damage muscle folding bone, ulcer sore swells；
The function that there is Semen Cuscutae continuous wound absolutely, tonifying for the deficiency, benefit to be good for people.The power of Schisandra chinensis energy strengthening by means of tonics, medical value is high, has salubrity strong
The benefits of body.Radix cyathulae is used for injury from falling down, rheumatic arthralgia.Radix Salviae Miltiorrhizae has promoting blood circulation, and inducing meastruation to relieve menalgia, relieving restlessness and restlessness, cool blood disappears
The effect of carbuncle.Caulis Spatholobi has the effect of activating blood and relaxing tendons, nourishing blood for regulating menstruation；Eupolyphoge sinensis has promoting blood circulation to remove blood stasis, inducing meastruation to relieve menalgia effect.Cream
Perfume has effects that promoting blood circulation, promoting the circulation of qi, analgesic；Myrrh has effects that dissolving stasis, detumescence, analgesic therapy；Safflower has blood circulation, dissipates the stasis of blood
The effect of analgesic；Radix Angelicae Sinensis has effects that replenishing and activating blood, menstruction regulating and pain relieving, moisturizing dryness and lubricating intestine；Radix Astragali have enhancing body's immunity,
The effect of liver protection, diuresis, anti-aging, resisting stress；
Radix Paeoniae Alba has blood-supplementing blood-nourishing, suppressing liver-YANG, the analgesic of soft liver, astringing YIN to stop sweating and other effects；There is rhizoma alismatis qi-restoratives to damage the exhaustion or lesion of the five internal organs,
The effect of except the five internal organs feeling of fullness；Herba Lycopi has the effect of wind dispelling analgesia；Radix Angelicae Pubescentis has the effect of dispelling wind and eliminating dampness, arthritis relieves pain；Rhizoma Chuanxiong
With blood-activating and qi-promoting, the effect of wind-expelling pain-stopping, Radix Glycyrrhizae has the effect of clearing heat and detoxicating.
Using the above scheme, native copper is synthetism panacea to the present invention, is monarch.The rhizome of davallia, teasel, Semen Cuscutae, Schisandra chinensis,
The raw marrow of radix cyathulae kidney tonifying is minister, Radix Salviae Miltiorrhizae, Caulis Spatholobi, Eupolyphoge sinensis, olibanum, myrrh, safflower, Radix Angelicae Sinensis, Radix Astragali, Radix Paeoniae Alba, rhizoma alismatis, Herba Lycopi,
Radix Angelicae Pubescentis activating microcirculation and removing stasis medicinal, promoting flow of qi and blood circulation analgesic are assistant.Rhizoma Chuanxiong, Radix Glycyrrhizae are gas medicine in blood, and coordinating the drug actions of a prescription is to make, and the present invention is with kidney tonifying
This, assistant is mark with promoting flow of qi and blood circulation dredging collateral.Treating both manifestation and root cause of disease, medicine disease are in step with, then control and test.We cure mainly fracture surgery poroma and generate slowly,
The extended patient of healing time has special efficacy.
By clinical test, the present invention has good curative effect to accelerating union of bone fracture, and toxic side effect is small, prevents long-term clothes
Injury with drug to taste internal organs, medication are safer.Each course for the treatment of is 30 days, and a course for the treatment of is applied with primary, external application 1~3
It can be cured after a course for the treatment of, cure rate is up to 88.5% or more.
The present invention passes through reasonable compatibility, the synergistic effect of each Chinese medicine, and treating both manifestation and root cause of disease can be promoted by adjusting and reinforcing liver and kidney
Growth of spur improves the activity and quantity of osteoblast, promotes calcified bone matrix, accelerates poroma transformation, moreover it is possible to alleviate part pain
Bitterly, there are more advantages than simple compound and biological agent.
Specific embodiment
Embodiment 1: a kind of raw marrow symplectic bone agent of the kidney tonifying of accelerating union of bone fracture is made of the bulk pharmaceutical chemicals of following parts by weight:
Native copper 45g, rhizome of davallia 12g, teasel 10g, Semen Cuscutae 10g, Schisandra chinensis 10g, radix cyathulae 12g, Radix Salviae Miltiorrhizae 12g, Caulis Spatholobi
12g, Eupolyphoge sinensis 12g, olibanum 10g, myrrh 10g, safflower 10g, Radix Angelicae Sinensis 10g, Radix Astragali 25g, Radix Paeoniae Alba 12g, rhizoma alismatis 10g, Herba Lycopi 10g,
Radix Angelicae Pubescentis 10g, Rhizoma Chuanxiong 10g, Radix Glycyrrhizae 8g are decocted in water for oral dose.
Embodiment 2: a kind of raw marrow symplectic bone agent of the kidney tonifying of accelerating union of bone fracture is made of the bulk pharmaceutical chemicals of following parts by weight:
Native copper 50g, rhizome of davallia 15g, teasel 12g, Semen Cuscutae 12g, Schisandra chinensis 12g, radix cyathulae 15g, Radix Salviae Miltiorrhizae 15g, Caulis Spatholobi
15g, Eupolyphoge sinensis 15g, olibanum 12g, myrrh 12g, safflower 12g, Radix Angelicae Sinensis 12g, Radix Astragali 30g, Radix Paeoniae Alba 15g, rhizoma alismatis 12g, Herba Lycopi 12g,
Radix Angelicae Pubescentis 12g, Rhizoma Chuanxiong 12g, Radix Glycyrrhizae 9g are decocted in water for oral dose.
Embodiment 3: a kind of raw marrow symplectic bone agent of the kidney tonifying of accelerating union of bone fracture is made of the bulk pharmaceutical chemicals of following parts by weight:
Native copper 55g, rhizome of davallia 18g, teasel 15g, Semen Cuscutae 15g, Schisandra chinensis 15g, radix cyathulae 18g, Radix Salviae Miltiorrhizae 18g, Caulis Spatholobi
18g, Eupolyphoge sinensis 18g, olibanum 15g, myrrh 15g, safflower 15g, Radix Angelicae Sinensis 15g, Radix Astragali 35g, Radix Paeoniae Alba 18g, rhizoma alismatis 15g, Herba Lycopi 15g,
Radix Angelicae Pubescentis 15g, Rhizoma Chuanxiong 15g, Radix Glycyrrhizae 10g are decocted in water for oral dose.
For the clinical efficacy and safety for further investigating above-described embodiment drug, we have selected the disease of 800 fracture
Example carries out clinical test to the treatment curative effect of drug of the present invention.
The patient that 800 are fractured is randomly divided into four groups, every group 200.In control group, male 100, women 100；
20 years old or less 15,21~35 years old 65,36~50 years old 70,51 years old or more 50；In treatment group 1, male 100, women
100；20 years old or less 14,21~35 years old 63,36~50 years old 71,51 years old or more 52；In treatment group 2, male 105
Example, women 95；20 years old or less 15,21~35 years old 64,36~50 years old 69,51 years old or more 52；In treatment group 3, male
Property 100, women 100；20 years old or less 14,21~35 years old 62,36~50 years old 70,51 years old or more 54.
Four groups of cases are comparable in terms of sex, age, course of disease, etc. through statistical analysis.
Control group is treated using the drug of common oral accelerating union of bone fracture；1 institute of the present embodiment is taken orally in treatment group 1
Drug obtained；Drug obtained by the present embodiment 2 is taken orally in treatment group 2；Drug obtained by the present embodiment 3 is taken orally in treatment group 3,
Three groups for the treatment of groups are all daily early, late each one, 7 days as one therapeutic courses, are spaced 2-3 days, continuously take the 2-3 course for the treatment of.
Criterion of therapeutical effect: cure: union is complete, heading line off of fracturing；Effective: fracture end has apparent poroma to be formed, bone
Broken line is fuzzy；Effective: fracture end has apparent poroma to be formed, and fracture gap narrows, activity without exception；Invalid: fracture end is without bright
Aobvious poroma is formed, and fracture line is high-visible, is had no difference to that before treatment.Curative effect comparision result such as table after four groups of case treatments
One.
Table one
| Group | Number of cases | It cures n (%) | Effective n (%) | Effective n (%) | Invalid n (%) |
| Control group | 200 | 154(77) | 162(81) | 175(87.5) | 25(12.5) |
| Treatment group 1 | 200 | 177(88.5) | 187(93.5) | 191(95.5) | 9(4.5) |
| Treatment group 2 | 200 | 178(89) | 188(94) | 192(96) | 8(4) |
| Treatment group 3 | 200 | 177(88.5) | 187(93.5) | 191(95.5) | 9(4.5) |
Pass through above-mentioned control, it can be seen that using Chinese medicine of the present invention treatment fracture, therapeutic effect is significant, with conventional oral medicine
Object is compared, and cure rate is high.
The present invention has good curative effect to accelerating union of bone fracture, and has no toxic side effect, and does not develop drug resistance, and treats for one within 7 days
Journey after taking a course for the treatment of, is spaced 2-3 days, is further continued for taking next course for the treatment of, continuously take the 2-3 course for the treatment of, is applied with 1~3
It can be cured after the course for the treatment of, cure rate is efficient up to 95.5% up to 88.5% or more.
It is as follows that some patientss cure case:
Field, male, 28 years old, fracture of tibia, after taking 2 courses for the treatment of of drug obtained by the present embodiment 1, patient symptom disappeared
It loses, recovery from illness.
Certain is shut out, female, 39 years old, fracture of head of femur, after taking 3 courses for the treatment of of drug obtained by the present embodiment 2, patient symptom disappeared
It loses, recovery from illness.
Poplar, male, 41 years old, fracture of nasal bone, after taking 1 course for the treatment of of drug obtained by the present embodiment 3, patient symptom disappeared
It loses, recovery from illness.
Mr. Luo, male, 18 years old, comminuted fracture of patella, after taking 3 courses for the treatment of of drug obtained by the present embodiment 2, patient's disease
Shape disappears, recovery from illness.
Claims (1)
1. a kind of raw marrow symplectic bone agent of the kidney tonifying of accelerating union of bone fracture, it is characterised in that: be made of the bulk pharmaceutical chemicals of following parts by weight:
Native copper 50g, rhizome of davallia 15g, teasel 12g, Semen Cuscutae 12g, Schisandra chinensis 12g, radix cyathulae 15g, Radix Salviae Miltiorrhizae 15g, Caulis Spatholobi
15g, Eupolyphoge sinensis 15g, olibanum 12g, myrrh 12g, safflower 12g, Radix Angelicae Sinensis 12g, Radix Astragali 30g, Radix Paeoniae Alba 15g, rhizoma alismatis 12g, Herba Lycopi 12g,
Radix Angelicae Pubescentis 12g, Rhizoma Chuanxiong 12g, Radix Glycyrrhizae 9g are decocted in water for oral dose.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510167338.0A CN104800443B (en) | 2015-04-02 | 2015-04-02 | A kind of raw marrow symplectic bone agent of kidney tonifying |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510167338.0A CN104800443B (en) | 2015-04-02 | 2015-04-02 | A kind of raw marrow symplectic bone agent of kidney tonifying |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104800443A CN104800443A (en) | 2015-07-29 |
| CN104800443B true CN104800443B (en) | 2019-01-22 |
Family
ID=53685927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510167338.0A Expired - Fee Related CN104800443B (en) | 2015-04-02 | 2015-04-02 | A kind of raw marrow symplectic bone agent of kidney tonifying |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104800443B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105412462A (en) * | 2015-12-18 | 2016-03-23 | 东阳市人民医院 | Bone setting granules and production method thereof |
| CN105998439A (en) * | 2016-07-15 | 2016-10-12 | 王士杰 | Symplectic bone medicine and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101623415A (en) * | 2009-08-07 | 2010-01-13 | 葛超顺 | Traditional Chinese medicine preparation for treating fractures and bone injuries |
| CN102579605A (en) * | 2012-03-12 | 2012-07-18 | 高永学 | Oral Chinese medicinal composition for treating bone fracture diseases |
| CN103877556A (en) * | 2014-04-17 | 2014-06-25 | 崔贵成 | Traditional Chinese medicine plaster for bone injury and fracture |
-
2015
- 2015-04-02 CN CN201510167338.0A patent/CN104800443B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101623415A (en) * | 2009-08-07 | 2010-01-13 | 葛超顺 | Traditional Chinese medicine preparation for treating fractures and bone injuries |
| CN102579605A (en) * | 2012-03-12 | 2012-07-18 | 高永学 | Oral Chinese medicinal composition for treating bone fracture diseases |
| CN103877556A (en) * | 2014-04-17 | 2014-06-25 | 崔贵成 | Traditional Chinese medicine plaster for bone injury and fracture |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104800443A (en) | 2015-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102309644B (en) | Traditional Chinese medical composition for treating bone fracture | |
| CN100506274C (en) | Traditional Chinese medicine for treating cervical vertebra disease | |
| CN103536858B (en) | Medicine for treating rheumatoid arthritis | |
| CN102895460B (en) | Traditional Chinese medicine composition for fracture and soft tissue injury | |
| CN105560662A (en) | External-use traditional Chinese medicine composition for treating knee osteoarthritis | |
| CN102247497A (en) | Chinese patent medicine for treating rheumatoid arthritis | |
| CN104758659A (en) | Traditional Chinese medicine paste for treating muscle and bone diseases | |
| CN107854683A (en) | A kind of plaster for treating damp and hot numbness type knee osteoarthritis | |
| CN104800443B (en) | A kind of raw marrow symplectic bone agent of kidney tonifying | |
| CN103285203B (en) | Traditional Chinese medicine composition for preventing and treating bone fracture and preparation method thereof | |
| CN105232905A (en) | Traditional Chinese medicine preparation for treating hyperostosis and preparing method of traditional Chinese medicine preparation | |
| CN105031447B (en) | A kind of Chinese medicine composition and preparation method thereof for treating fracture | |
| CN103585483B (en) | Traditional Chinese medicine composition for treating knee osteoarthritis and preparation method of same | |
| CN105287731A (en) | Externally-applied traditional Chinese medicine preparation for treating hyperostosis and preparation method thereof | |
| CN112755134B (en) | Plaster for treating hyperosteogeny and preparation method thereof | |
| CN103191305A (en) | Traditional Chinese medicine composition for treating hyperosteogeny | |
| CN106924673A (en) | A kind of Chinese medicine composition for treating osteoproliferation and its medicament preparation method | |
| CN106177775A (en) | A kind of Chinese medicine composition treating hyperosteogeny | |
| CN106474316A (en) | A kind of Chinese medicine for treating PLB | |
| CN106109965A (en) | A kind of Chinese medicine composition treating flaccidity disease | |
| CN105381071A (en) | Traditional Chinese medicine composition for treating fractures | |
| CN105998302A (en) | Foot bath powder for treating arthritis and preparation method of foot bath powder | |
| CN104383424A (en) | Pharmaceutical composition for promoting fracture healing | |
| CN110115750A (en) | A kind of relaxing tendons and activating collaterals composition and its preparation method and application | |
| CN104758539A (en) | Traditional Chinese medicine composition for treating debilitation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20190122 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |